Nitric oxide synthase activity in human breast cancer - PubMed (original) (raw)
Nitric oxide synthase activity in human breast cancer
L L Thomsen et al. Br J Cancer. 1995 Jul.
Free PMC article
Abstract
Nitric oxide (NO) is generated by a family of isoenzymes (NO synthases) expressed in a wide range of mammalian cells. We have recently reported NO synthase expression in human gynaecological cancers. In this study we have assessed the activity and distribution of NO synthase in a series of human breast tumours and in normal breast tissue. Calcium-dependent (constitutive) and -independent (inducible) NO synthase activity, as well as NO biosynthesis, was high in invasive tumours compared with benign or normal tissue. Furthermore, for invasive ductal carcinomas, NO biosynthesis was significantly greater for grade III compared with grade II tumours. Immunohistochemical investigations revealed immunolabelling with a monoclonal antibody to murine inducible NO synthase predominantly within tumour-associated macrophages. Immunolabelling with a polyclonal antiserum raised against rat brain NO synthase was also observed in vascular endothelial and myoepithelial cells. Thus NO synthase is expressed in human breast tumours, where its presence correlates with tumour grade.
Similar articles
- Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia.
Tschugguel W, Knogler W, Czerwenka K, Mildner M, Weninger W, Zeillinger R, Huber JC. Tschugguel W, et al. Br J Cancer. 1996 Nov;74(9):1423-6. doi: 10.1038/bjc.1996.559. Br J Cancer. 1996. PMID: 8912539 Free PMC article. - Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer.
Martin JH, Begum S, Alalami O, Harrison A, Scott KW. Martin JH, et al. Tumour Biol. 2000 Mar-Apr;21(2):90-7. doi: 10.1159/000030114. Tumour Biol. 2000. PMID: 10686538 - Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade.
Tschugguel W, Schneeberger C, Unfried G, Czerwenka K, Weninger W, Mildner M, Gruber DM, Sator MO, Waldhör T, Huber JC. Tschugguel W, et al. Breast Cancer Res Treat. 1999 Jul;56(2):145-51. doi: 10.1023/a:1006288526311. Breast Cancer Res Treat. 1999. PMID: 10573107 - Regulation and dysregulation of constitutive nitric oxide synthases types I and III.
Schmidt HH, Hofmann H, Ogilvie P. Schmidt HH, et al. Curr Top Microbiol Immunol. 1995;196:75-86. doi: 10.1007/978-3-642-79130-7_8. Curr Top Microbiol Immunol. 1995. PMID: 7543401 Review. No abstract available. - Isoforms of nitric oxide synthase: functions in the cardiovascular system.
Förstermann U, Nakane M, Tracey WR, Pollock JS. Förstermann U, et al. Eur Heart J. 1993 Nov;14 Suppl I:10-5. Eur Heart J. 1993. PMID: 7507435 Review.
Cited by
- NO- and H2S- releasing nanomaterials: A crosstalk signaling pathway in cancer.
Dos Reis RA, Sarkar I, Rodrigues MG, Matson JB, Seabra AB, Kashfi K. Dos Reis RA, et al. Nitric Oxide. 2024 Oct 1;151:17-30. doi: 10.1016/j.niox.2024.08.002. Epub 2024 Aug 22. Nitric Oxide. 2024. PMID: 39179197 Review. - Spin Trapping of Nitric Oxide by Hemoglobin and Ferrous Diethyldithiocarbamate in Model Tumors Differing in Vascularization.
Szczygieł D, Szczygieł M, Łaś A, Elas M, Zuziak R, Płonka BK, Płonka PM. Szczygieł D, et al. Int J Mol Sci. 2024 Apr 10;25(8):4172. doi: 10.3390/ijms25084172. Int J Mol Sci. 2024. PMID: 38673758 Free PMC article. - Nitric oxide, thyroglobulin, and calcitonin: unraveling the nature of thyroid nodules.
Samardzic VS, Macvanin MT, Zafirovic SS, Obradovic MM, Gluvic ZM, Grubin J, Gao X, Essack M, Isenovic ER. Samardzic VS, et al. Front Endocrinol (Lausanne). 2023 Sep 28;14:1241223. doi: 10.3389/fendo.2023.1241223. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37842300 Free PMC article. - Non-viral nitric oxide-based gene therapy improves perfusion and liposomal doxorubicin sonopermeation in neuroblastoma models.
Bellary A, Nowak C, Iwanicki I, Flores-Guzman F, Wu L, Kandel JJ, Laetsch TW, Bleris L, Hernandez SL, Sirsi SR. Bellary A, et al. Theranostics. 2023 Jun 4;13(10):3402-3418. doi: 10.7150/thno.81700. eCollection 2023. Theranostics. 2023. PMID: 37351172 Free PMC article. - Triphenyltin(IV) Carboxylates with Exceptionally High Cytotoxicity against Different Breast Cancer Cell Lines.
Predarska I, Saoud M, Morgan I, Lönnecke P, Kaluđerović GN, Hey-Hawkins E. Predarska I, et al. Biomolecules. 2023 Mar 26;13(4):595. doi: 10.3390/biom13040595. Biomolecules. 2023. PMID: 37189343 Free PMC article.
References
- J Natl Cancer Inst. 1992 Dec 16;84(24):1875-87 - PubMed
- Histochemistry. 1992 Nov;98(4):259-66 - PubMed
- Biochem J. 1993 Jan 15;289 ( Pt 2):357-61 - PubMed
- Biochem Biophys Res Commun. 1993 Apr 30;192(2):505-10 - PubMed
- Biochemistry. 1993 Nov 2;32(43):11600-5 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical